AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46
EXPOSURE TO BREAST-MILK IN INFANCY AND ADULT BREAST-CANCER RISK
Authors: TITUSERNSTOFF L EGAN KM NEWCOMB PA BARON JA STAMPFER M GREENBERG ER COLE BF DING J WILLETT W TRICHOPOULOS D
Citation: L. Titusernstoff et al., EXPOSURE TO BREAST-MILK IN INFANCY AND ADULT BREAST-CANCER RISK, Journal of the National Cancer Institute, 90(12), 1998, pp. 921-924
PHASE-II TRIAL OF WEEKLY PACLITAXEL AND CONCURRENT RADIATION-THERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER
Authors: CHOY H SAFRAN H AKERLEY W GRAZIANO SL BOGART JA COLE BF
Citation: H. Choy et al., PHASE-II TRIAL OF WEEKLY PACLITAXEL AND CONCURRENT RADIATION-THERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER, Clinical cancer research, 4(8), 1998, pp. 1931-1936
QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING
Authors: COLE BF SOLALCELIGNY P GELBER RD LEPAGE E GISSELBRECHT C REYES F SEBBAN C SUGANO D TENDLER C GOLDHIRSCH A
Citation: Bf. Cole et al., QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING, Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
HIGH-DOSE INTRAVENOUS METHOTREXATE FOR PATIENTS WITH NONLEUKEMIC LEPTOMENINGEAL CANCER - IS INTRATHECAL CHEMOTHERAPY NECESSARY
Authors: GLANTZ MJ COLE BF RECHT L AKERLEY W MILLS P SARIS S HOCHBERG F CALABRESI P EGORIN MJ
Citation: Mj. Glantz et al., HIGH-DOSE INTRAVENOUS METHOTREXATE FOR PATIENTS WITH NONLEUKEMIC LEPTOMENINGEAL CANCER - IS INTRATHECAL CHEMOTHERAPY NECESSARY, Journal of clinical oncology, 16(4), 1998, pp. 1561-1567
CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY
Authors: COLE BF GELBER RD GOLDHIRSCH A
Citation: Bf. Cole et al., CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY, Journal of clinical oncology, 16(11), 1998, pp. 3718-3718
SURVIVAL BENEFIT IN MELANOMA
Authors: COLE BF GELBER RD KIRKWOOD JM
Citation: Bf. Cole et al., SURVIVAL BENEFIT IN MELANOMA, Journal of clinical oncology, 16(1), 1998, pp. 388-389
QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES
Authors: GLASZIOU PP COLE BF GELBER RD HILDEN J SIMES RJ
Citation: Pp. Glasziou et al., QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES, Statistics in medicine, 17(11), 1998, pp. 1215-1229
UNEXPECTED IN-VITRO CHEMOSENSITIVITY OF MALIGNANT GLIOMAS TO 4-HYDROXYPEROXYCYCLOPHOSPHAMIDE (4-HC)
Authors: RECHT LD GLANTZ MJ MEITNER P GLANTZ L AKERLEY W WAHLBERG L SARIS S COLE BF
Citation: Ld. Recht et al., UNEXPECTED IN-VITRO CHEMOSENSITIVITY OF MALIGNANT GLIOMAS TO 4-HYDROXYPEROXYCYCLOPHOSPHAMIDE (4-HC), Journal of neuro-oncology, 36(3), 1998, pp. 201-208
PREDICTING PROBABILITIES OF PREGNANCY AND MULTIPLE GESTATION FROM IN-VITRO FERTILIZATION - A NEW MODEL
Authors: WHEELER CA COLE BF FRISHMAN GN SEIFER DB LOVEGREEN SB HACKETT RJ
Citation: Ca. Wheeler et al., PREDICTING PROBABILITIES OF PREGNANCY AND MULTIPLE GESTATION FROM IN-VITRO FERTILIZATION - A NEW MODEL, Obstetrics and gynecology, 91(5), 1998, pp. 696-700
SPECIFIC MATRIX METALLOPROTEINASE PROFILES IN THE CEREBROSPINAL-FLUIDCORRELATED WITH THE PRESENCE OF MALIGNANT ASTROCYTOMAS, BRAIN METASTASES, AND CARCINOMATOUS MENINGITIS
Authors: FRIEDBERG MH GLANTZ MJ KLEMPNER MS COLE BF PERIDES G
Citation: Mh. Friedberg et al., SPECIFIC MATRIX METALLOPROTEINASE PROFILES IN THE CEREBROSPINAL-FLUIDCORRELATED WITH THE PRESENCE OF MALIGNANT ASTROCYTOMAS, BRAIN METASTASES, AND CARCINOMATOUS MENINGITIS, Cancer, 82(5), 1998, pp. 923-930
CEREBROSPINAL-FLUID CYTOLOGY IN PATIENTS WITH CANCER - MINIMIZING FALSE-NEGATIVE RESULTS
Authors: GLANTZ MJ COLE BF GLANTZ LK COBB J MILLS P LEKOS A WALTERS BC RECHT LD
Citation: Mj. Glantz et al., CEREBROSPINAL-FLUID CYTOLOGY IN PATIENTS WITH CANCER - MINIMIZING FALSE-NEGATIVE RESULTS, Cancer, 82(4), 1998, pp. 733-739
WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE
Authors: GLANTZ MJ CHOY H AKERLEY W KEARNS CM EGORIN MJ RHODES CH COLE BF
Citation: Mj. Glantz et al., WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE, Seminars in radiation oncology, 7(2), 1997, pp. 25-33
GP120-DIRECTED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AS A MAJOR DETERMINANT OF THE RATE OF DECLINE IN CD4 PERCENTAGE IN HIV-1 DISEASE
Authors: SKOWRON G COLE BF ZHENG D ACCETTA G YENLIEBERMAN B
Citation: G. Skowron et al., GP120-DIRECTED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AS A MAJOR DETERMINANT OF THE RATE OF DECLINE IN CD4 PERCENTAGE IN HIV-1 DISEASE, AIDS, 11(15), 1997, pp. 1807-1814
EFFICACY, SAFETY, AND RISK-BENEFIT ANALYSIS OF ADJUVANT INTERFERON ALFA-2B IN MELANOMA
Authors: KIRKWOOD JM RESNICK GD COLE BF
Citation: Jm. Kirkwood et al., EFFICACY, SAFETY, AND RISK-BENEFIT ANALYSIS OF ADJUVANT INTERFERON ALFA-2B IN MELANOMA, Seminars in oncology, 24(1), 1997, pp. 16-23
NATURAL-HISTORY OF SEIZURES AND THE ROLE OF ANTICONVULSANTS (AC) IN PATIENTS (PTS) WITH PRIMARY AND METASTATIC CENTRAL-NERVOUS-SYSTEM (CNS)CANCER
Authors: COBB JL LEKOS A COLE BF RECHT L MILLS PC GLANTZ MJ
Citation: Jl. Cobb et al., NATURAL-HISTORY OF SEIZURES AND THE ROLE OF ANTICONVULSANTS (AC) IN PATIENTS (PTS) WITH PRIMARY AND METASTATIC CENTRAL-NERVOUS-SYSTEM (CNS)CANCER, Neurology, 48(3), 1997, pp. 1006-1006
MUTATED P53 GENE IS AN INDEPENDENT ADVERSE PREDICTOR OF SURVIVAL IN COLON-CARCINOMA
Authors: PRICOLO VE FINKELSTEIN SD HANSEN K COLE BF BLAND KI
Citation: Ve. Pricolo et al., MUTATED P53 GENE IS AN INDEPENDENT ADVERSE PREDICTOR OF SURVIVAL IN COLON-CARCINOMA, Archives of surgery, 132(4), 1997, pp. 371-374
EVALUATING THE CLINICAL AND ECONOMIC TRADE-OFFS OF HEPATIC ARTERIAL INFUSION
Authors: COLE BF
Citation: Bf. Cole, EVALUATING THE CLINICAL AND ECONOMIC TRADE-OFFS OF HEPATIC ARTERIAL INFUSION, Journal of the National Cancer Institute, 88(5), 1996, pp. 223-224
A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER - RESPONSE
Authors: GELBER RD GOLDHIRSCH A COLE BF KROOK JE
Citation: Rd. Gelber et al., A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER - RESPONSE, Journal of the National Cancer Institute, 88(22), 1996, pp. 1686-1686
A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER
Authors: GELBER RD GOLDHIRSCH A COLE BF WIEAND HS SCHROEDER G KROOK JE
Citation: Rd. Gelber et al., A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER, Journal of the National Cancer Institute, 88(15), 1996, pp. 1039-1045
OPTIONS AND RESULTS FOR THE MANAGEMENT OF MINIMALLY INVASIVE, CARCINOMA OF THE BREAST - INFLUENCE OF AXILLARY DISSECTION FOR TREATMENT OF T1A AND T1B LESIONS
Authors: WHITE RE VEZERIDIS MP KONSTADOULAKIS M COLE BF WANEBO HJ BLAND KI
Citation: Re. White et al., OPTIONS AND RESULTS FOR THE MANAGEMENT OF MINIMALLY INVASIVE, CARCINOMA OF THE BREAST - INFLUENCE OF AXILLARY DISSECTION FOR TREATMENT OF T1A AND T1B LESIONS, Journal of the American College of Surgeons, 183(6), 1996, pp. 575-582
PHASE-I STUDY OF WEEKLY OUTPATIENT PACLITAXEL AND CONCURRENT CRANIAL IRRADIATION IN ADULTS WITH ASTROCYTOMAS
Authors: GLANTZ MJ CHOY H KEARNS CM COLE BF MILLS P ZUHOWSKI EG SARIS S RHODES CH STOPA E EGORIN MJ
Citation: Mj. Glantz et al., PHASE-I STUDY OF WEEKLY OUTPATIENT PACLITAXEL AND CONCURRENT CRANIAL IRRADIATION IN ADULTS WITH ASTROCYTOMAS, Journal of clinical oncology, 14(2), 1996, pp. 600-609
QUALITY-OF-LIFE - ADJUSTED SURVIVAL ANALYSIS OF INTERFERON ALFA-2B ADJUVANT TREATMENT OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
Authors: COLE BF GELBER RD KIRKWOOD JM GOLDHIRSCH A BARYLAK E BORDEN E
Citation: Bf. Cole et al., QUALITY-OF-LIFE - ADJUSTED SURVIVAL ANALYSIS OF INTERFERON ALFA-2B ADJUVANT TREATMENT OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 14(10), 1996, pp. 2666-2673
ADJUVANT CHEMOTHERAPY PLUS TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE FOR POSTMENOPAUSAL BREAST-CANCER - METAANALYSIS OF QUALITY-ADJUSTED SURVIVAL
Authors: GELBER RD COLE BF GOLDHIRSCH A ROSE C FISHER B OSBORNE CK BOCCARDO F GRAY R GORDON NH BENGTSSON NO SEVELDA P
Citation: Rd. Gelber et al., ADJUVANT CHEMOTHERAPY PLUS TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE FOR POSTMENOPAUSAL BREAST-CANCER - METAANALYSIS OF QUALITY-ADJUSTED SURVIVAL, Lancet, 347(9008), 1996, pp. 1066-1071
WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE
Authors: GLANTZ MJ CHOY H AKERLEY W KEARNS CM EGORIN MJ RHODES CH COLE BF
Citation: Mj. Glantz et al., WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE, Seminars in oncology, 23(6), 1996, pp. 128-135
A RANDOMIZED, BLINDED, PLACEBO-CONTROLLED TRIAL OF DIVALPROEX SODIUM PROPHYLAXIS IN ADULTS WITH NEWLY-DIAGNOSED BRAIN-TUMORS
Authors: GLANTZ MJ COLE BF FRIEDBERG MH LATHI E CHOY H FURIE K AKERLEY W WAHLBERG L LEKOS A LOUIS S
Citation: Mj. Glantz et al., A RANDOMIZED, BLINDED, PLACEBO-CONTROLLED TRIAL OF DIVALPROEX SODIUM PROPHYLAXIS IN ADULTS WITH NEWLY-DIAGNOSED BRAIN-TUMORS, Neurology, 46(4), 1996, pp. 985-991
Risultati: 1-25 | 26-46